Ekso Bionics Holdings, Inc. Overview
Pro stress-test →Ekso Bionics designs, develops, and commercializes exoskeleton technology that amplifies human strength, endurance, and mobility for medical and industrial applications. The company operates two segments—EksoHealth for rehabilitation and EksoWorks for industrial use—positioning itself as a leader in robotics solutions that restore and enhance human function across diverse markets.
Strategic Profile
Pro stress-test →The company demonstrates strong recovery momentum with Q3 2025 revenues up 105% sequentially to $4.2M and gross margins improving to 60.3%. Recent strategic moves include a non-binding merger agreement with Applied Digital Cloud and exclusive U.S. distribution deals for complementary rehabilitation systems like MediTouch's BalanceTutor, strengthening its competitive positioning in the growing robotics healthcare sector.
Competitive Landscape
Pro stress-test →Ekso competes in the medical robotics and exoskeleton sector against larger, better-capitalized companies and specialized robotics firms. Main competition comes from established medical device companies and emerging robotics startups. Ekso differentiates through comprehensive product range spanning clinical rehabilitation through industrial applications, though it lacks the scale and market presence of larger peers in both the medical device and industrial robotics industries.
Industry Context
Ekso Bionics Holdings, Inc. operates in Medical Robotics / Exoskeleton Technology / Industrial Rehabilitation.
Key facts
Headquarters: San Francisco Bay Area, US · Revenue: $4.2M (Q3 2025) · Market cap: $24.5M